Point of Care Strep Tests Speed Treatment, Lower Costs
... testing, some controversy remains in the clinical community about the need for agar incubation culture as a confirmatory procedure following a positive RADT and prior to the initiation of antibiotic therapy or as a reassay in those instances when RADT results are negative yet clinical findings support a diagn...Avian (Bird) Flu: Is There a Role for Rapid Tests?
...ne must bear in mind that avian flu may exist in a community amid other subtypes such as A/H1, A/H3, and B. At the present time, no rapid flu test can differentiate avian flu from other subtypes. Therefore, despite the proven ability of some rapid flu tests to detect H5N1 (see below), these tests have no pos...Tercica to Present at Investment Conferences
...ced that Company management will make aninvestment community presentation at the C.E. Unterberg, TowbinEmerging...gendocrine health by partnering with the endocrine community todevelop and commercialize new therapeutics for short stature andother metabolic disorders. For fur...MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
...lays aninstrumental role in providing the oncology community with the mostup-to-date scientific research and information available. Throughits flagship journal, Annals of Oncology, ESMO publishes articleson all aspects of clinical oncology. ESMO is dedicated to educatingand supporting oncologists, optimizing p...From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
...hals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer through high-qualityscientific and educational programs. It funds innovative,meritorious research grants. The AACR Annual Meeting attracts morethan 17,000 participants who sha...Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
...hals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer through high-qualityscientific and educational programs. It funds innovative,meritorious research grants. The AACR Annual Meeting attracts morethan 17,000 participants who sha...Researchers Discover Method for Identifying How Cancer Evades the Immune System
...hals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer through high-qualityscientific and educational programs. It funds innovative,meritorious research grants. The AACR Annual Meeting attracts morethan 17,000 participants who sha...Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
...hals the fullspectrum of expertise from the cancer community to accelerateprogress in the prevention, diagnosis and treatment of cancerthrough high-quality scientific and educational programs. It fundsinnovative, meritorious research grants. The AACR Annual Meetingattracts more than 17,000 participants who sha......a novel once-a-day antibiotic, forthe treatment of community acquired pneumonia (CAP). The Companyalso provided an update to the projected timeline for announcementof top-line data from the second CAP study, Trial CL-05. The Company is hosting a conference call and live webcast at10:00 am (EDT) today, July 2,......a novel once-a-day antibiotic, forthe treatment of community acquired pneumonia (CAP). Conference Call Details: The conference call will be webcast simultaneously over theInternet. Please visit the Investor Relations section of theAdvanced Life Sciences corporate website <a target="_blank" href="http://w......avea major impact on the acceptance of the medical community and thepublic to store stem cells from this abundant source," said Dr.Geoffrey O'Neill, Chief Scientific Advisor of Bio-Matrix ScientificGroup Inc. Until now, banking of fat derived stem cells has focused onfuture regenerative medicine procedures su...Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839
...lead product, faropenemmedoxomil, is a novel oral, community antibiotic, expected to beappropriate for use as a first-line antibiotic for treatment ofrespiratory and skin infections in adult and pediatric patients.Replidyne's second drug candidate, REP8839, is a topicalanti-infective product candidate in devel...New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
...tiative enablesparticipating hospitals to focus on community needs while providingthe strength of national support. Please visit <a target="_blank"href="http://www.spiritofwomen.com/">www.spiritofwomen.com foradditional information. Contact: Tara DiMilia, 908-369-7168 (1) FDA website - <......of Bentley. "For more than two decades,the medical community has been searching for a less painful andeasier method for treating diabetes than insulin injections.Nasulin presents a significant opportunity of achieving this goalfor many patients and has the potential for significantly betterpatient compliance t......nore the potential life-savinggift the infertility community is willing to give to support stemcell research - the gift of unused embryos to advance science andto help develop treatments for diseases such as cancer, diabetesand other debilitating illnesses," said Barbara Collura, ExecutiveDirector of RESOLVE: ...AMIA Announces 2008 Summit on Translational Bioinformatics
...n a whole new level of meaning andbenefit the AMIA community and health care as a whole." AMIA Board Director, Atul Butte, MD, PhD, Assistant Professor inMedicine (Medical Informatics) and Pediatrics at the StanfordUniversity School of Medicine and the Lucile Packard Children'sHospital, and a board-certifie......e the frontiers ofknowledge and to foster a campus community deeply engaged inunderstanding and addressing the ...ic service initiatives, culturalcollaborations and community partnerships help define theUniversity's underlying values and mission to educate students tobe both......tipleresearch institutes; and several outreach and community serviceunits. About Orchestra Therapeutics Orchestra Therapeutics, Inc., formerly The Immune ResponseCorporation , is an immuno-pharmaceutical company focused on thediscovery and development of novel treatments for autoimmunediseases. The Company's...Prana Biotechnology Presents New Key Findings on PBT2
...ates ofthe Abeta protein. The Alzheimer's research community largelysupports the hypothesis that small, soluble, mobile aggregates(oligomers) of the Abeta protein are the cause of neurotoxicity inAD. PBT2's ability to inhibit the generation and toxicity of theseoligomers, as well as preventing the hyperphospho...Study Shows Advantages of Complete Phase Ib Trial Over Separate Phase I Trials
...work. "Early-stage trials conducted in a smaller, community settingcan result in a speedier determination of a new agent's viability,eventually bringing new therapies to patients quicker." Each TOP site is required to have a dedicated physician,research nurse and investigational/research pharmacist who have ......o promote evidence-based medicine in a large community oncology practice -- Domingo Perez, M.D.: Phase II trial of carboplatin, weekly paclitaxel and biweekly bevacizumab in patients with unresectable stage IV melanoma -- Nicholas Robert, M.D., Co-Chair Breast Cancer Research Committee......ditional assurance to the interventionalcardiology community regarding the efficacy of the CYPHER(R) Stentto prevent the need for repeat revascularizations in a real-worldclinical setting," said David E. Kandzari, M.D., F.A.C.C.,F.S.C.A.I., Chief Medical Officer, Cordis Cardiology Division ofCordis Corporation...Waismann Method Survey Reveals Dependency Risk for People Using Suboxone
...nn."Rather than write prescriptions, the addiction community shoulddirect their efforts towards helping patients understand thatrelapse is not part of recovery. In addition, the antiquated notionthat addiction is an incurable disease and belief that 'once anaddict, always an addict,' needs to be dispelled. Pat......in the fields of MS healthcare, research,advocacy, community service and education to keep abreast of thelatest information on patient care delivery systems andevidence-based practice. Below are three highlights from the conference that reflect thecaliber of innovation and inspiration at the meeting. 1. ...Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
...iscovery'sbroad SRT pipeline. The neonatal medical community has repeatedlyindicated a strong interest in long-term outcomes assessment. Nosuch assessment from the registration trials supporting use ofcurrently prescribed animal-derived products has, to our knowledge,ever been conducted. Discovery is committed...... "The FDA, Cystic Fibrosis Foundation and medical community haveidentified PROs as important endpoints in clin...th regulatory authorities and with the CF research community indesigning this study and we thank the patients and investigatorsfor their participation. Based on ...Clinical Trial Excellence: Shaping Markets Through Early Communication of Clinical Trial Data
...e executive identified tailoring messages to community and patient advocacy groups by therapeutic area as the most innovative public relations activity. For example, the company hosts separate events for consumer and advocacy leaders in the community. Download the report excerpt online...Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug Candidate, Sphingomab
...y garnered considerable attention inthe scientific community as a validated mediator of fibrosis(scar-tissue formation), which contributes significantly toAMD-related vision loss. Lpath has demonstrated in previous studiesthat Sphingomab reduces scarring in a variety of organ systems byinhibiting S1P. "This i...NCCN Updates Esophageal and Gastric Cancer Guidelines
...f care in oncology in the United States inboth the community and the academic practice settings. In response to favorable Phase III trials (ML 17032 and REAL 2),the panel added oral fluoropyrimidine, Capecitabine (Xeloda(R),Roche) as an option for treatment of esophageal and gastric cancer.The REAL 2 study, th......rmaCare(R),PUR(R), Crest(R) and Oral-B(R). The P&G community consists ofover 135,000 employees working in over 80 countries worldwide.Please visit <a target="_blank" href="http://www.pg.com/">http://www.pg.com for the latest news andin-depth information about P&G and its brands. About Digestive Disea...Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
... to the forefront and assist the ulcerativecolitis community in identifying areas to focus our efforts." "Like many other chronic diseases, there's no medical cure forulcerative colitis, but with better management of quality of lifeissues, improved patient communication and by getting patients oneffective the......12 billion in 2000 (including costsincurred in the community and institutions). About the Study The double-blind trial included 34 patients with OAB andconfirmed IDO who had failed on a trial of anticholinergic therapyfor six weeks or more due to either poor efficacy or tolerability.They were randomly assign...Data Show FluMist May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings
...nation may provide abeneficial cost savings to the community at large. The results werepresented at the annual meeting of the Pediatric Academic Societies(PAS) taking place this week in Toronto, Canada. Additional datawere presented from a study showing that increased vaccinationrates may help prevent late-sea...Pluristem to Present Two Scientific Posters at the International Society for Cellular Therapy
...We arereceiving more attention from the scientific community as ourresearch and development team continues to successfully show howinnovative our Placenta eXpanded (PLX) cells are. These PLX cellsare mesenchymal stem cells expanded in our proprietary 3DPluriX(TM) Bioreactor System." Pluristem's presentations ...Cethromycin Shown Effective Against Anthrax in Study
...so inpivotal Phase III trials for the treatment of community acquiredpneumonia (CAP). The Company expects to report data from the CAPprogram in June of this year. "With emerging bacterial resistance, both natural andengineered, there is a critical need for new antibiotics that workdifferently than currently a......agues are receiving recognitionfrom the scientific community in developing a breakthrough thatcould expedite the development of important therapeutictreatments." About CytRx Corporation Los Angeles, California-based CytRx Corporation is abiopharmaceutical research and development company engaged in thedevelo...Aranesp ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
...first quarter financialresults with the investment community at 2:00 PM, Pacific Time,Monday, April 23, 2007. Live audio of the conference call will besimultaneously broadcast over the Internet and will be available tomembers of the news media, investors and the general public. Theconference call, including th...Micell Technologies Presents Data on Novel Drug-Eluting Stents
...he subjectof much recent discussion in the medical community and the media.These concerns have been driven largely by a number of issuesincluding inherently thrombogenic polymers, residual drugs andpatient compliance issues related to the necessary oralanti-platelet therapy such as Plavix and aspirin, required......hals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer through high-qualityscientific and educational programs. It funds innovative,meritorious research grants. The AACR Annual Meeting attracts morethan 17,000 participants who sha...AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical Pipeline to Be Featured at AACR
...nia. "We are very excited to share with the cancer community thepioneering oncology research platform AVEO has developed, which webelieve may significantly enhance the probability of success andthe efficacy of the next generation of targeted cancer therapies,"said Tuan Ha-Ngoc, president and CEO of AVEO Pharma...Newest Adult Stem Therapy Treats Diabetes
...y? Because much of theAmerican biomedical research community has placed an irrationalreliance on embryo stem cell research above all others. Adult stemcell science in America is being crowded out and in some casesignored. This bias is now denying American patients access totherapies that are much more promisin......earch results are provided to the worldwidemedical community through scientific publications and professionalmeetings About Celgene Celgene Corporation, headquartered in Summit, New Jersey, is anintegrated global biopharmaceutical company engaged primarily inthe discovery, development and commercialization o......fpatients, but there is controversy in the medical community aboutthe role NAbs may or may not play in a patient's response totherapy. "This study reinforces expert recommendations that treatmentdecisions should be based on a patient's overall response totherapy and not on the actual or potential presence of ...State of Diabetes in Pittsburgh: Pittsburgh Business Group on Health Releases Report
...fulfill its commitment to its employer members and community healthpartners to promote and maintain a high quality, efficient andaffordable health care delivery system. The report was producedwith assistance from sanofi-aventis U.S. LLC. The complete reportis available in electronic format on PBGH's website at...Arpida Announces Promising Results of "First-In-Man" Studies With AR-709
... most feared bacterium thatcauses pneumonia in the community setting. Since the first reportsof Streptococcus p... in the area of respiratory tractinfection. In the community setting, 67% of antibiotic use inadults and 87% in children is for the treatment of RTIs. Theantibac...Survey Reveals Significant Public Lack of Diabetes Awareness
...herapyoptions available to treat it. "The diabetes community has speculated for some time about thepublic's poor understanding of type 1 diabetes. These surveyresults unfortunately confirm our fears," said Francine Kaufman,MD, director of the Comprehensive Childhood Diabetes Center andhead of the Center for En...Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
...hile educating, supporting, and advocating for the community ofpatients, families, and medical professionals fi...nd works toimprove awareness of IPF in the medical community as well as thegeneral public. The CPF's nonprofit partners include many of themost respected medical...Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice
...hals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer through high-qualityscientific and educational programs. It funds innovative,meritorious research grants. The AACR Annual Meeting attracts morethan 17,000 participants who sha...Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III Trial for Hereditary Angioedema
...latory team, and, mostimportantly, the HAE patient community and its leaders who havebeen so supportive of our efforts," said Joshua D. Schein, Ph.D.,the company's Chief Executive Officer. About Hereditary Angioedema HAE, or hereditary C1-inhibitor deficiency, is a geneticdisorder characterized by recurrent ...Arpida adds novel antibiotic AR-2474 to its preclinical pipeline
... lower respiratory tractinfections acquired in the community setting. AR-709 exhibitedpotent activity against 611 pneumococcal clinical isolates fromEurope, the USA and Asia irrespective of the mechanisms ofresistance to currently used drugs. Arpida received authorisationto enter first-in-man studies with AR-7...La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
... data which should attract attentionfrom the lupus community since a reduction in antibodies to dsDNAis a biomarker we associate with clinical improvement." Dose Dependent Antibody Reduction The analyses assessed the impact of treatment with Riquent onreducing antibodies to dsDNA in 101 patients by measuring......lead product, faropenemmedoxomil, is a novel oral, community antibiotic, expected to beappropriate for use as a first-line antibiotic for treatment ofrespiratory and skin infections in adult and pediatric patients.Replidyne's second drug candidate, REP8839, is a topicalanti-infective product under Phase I deve...